ELDN
Eledon Pharmaceuticals Inc

6,310
Loading...
Loading...
News
all
press releases
Best Momentum Stocks to Buy for July 14th
ELDN, KDDIY and PENG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 14, 2025.
Zacks·2mo ago
News Placeholder
More News
News Placeholder
New Strong Buy Stocks for July 14th
WIT, KNOP, PENG, ELDN and KDDIY have been added to the Zacks Rank #1 (Strong Buy) List on July 14, 2025.
Zacks·2mo ago
News Placeholder
Eledon Pharmaceuticals Enacts Key Proposals and Board Changes
Eledon Pharmaceuticals (ELDN) just unveiled an announcement. Eledon Pharmaceuticals, Inc. stockholders convened on July 10, 2024, approving key pro...
TipRanks Financial Blog·1y ago
News Placeholder
Nano-Cap Eledon Pharmaceuticals' Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence
Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant...
Benzinga·1y ago
News Placeholder
Eledon Pharmaceuticals Risks Shareholder Equity Dilution Amidst Private Placement and Potential Stock Issuances
Eledon Pharmaceuticals, Inc. (ELDN) has disclosed a new risk, in the Share Price & Shareholder Rights category. Eledon Pharmaceuticals, Inc. faces...
TipRanks Financial Blog·1y ago
News Placeholder
Eledon Pharmaceuticals: A Strong Buy on the Back of Promising Clinical Trials and a Solid Financial Footing
In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Eledon Pharmaceuticals (ELDN Research Report), with a p...
TipRanks Financial Blog·1y ago
News Placeholder
Eledon Pharmaceuticals reports Q4 EPS (32c), consensus (39c)
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
Enrolled 12 participants in Phase 2 BESTOW trial evaluating tegoprubart for the prevention of kidney rejection Tegoprubart used as a component of the immunosuppressive treatment regimen following...
Globe Newswire·1y ago
News Placeholder
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection
IRVINE, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ( Eledon ) (NASDAQ: ELDN) today announced the enrollment of the 12th participant on March 23, 2024, in the Company's...
Globe Newswire·1y ago
News Placeholder
Eledon Pharmaceuticals (NASDAQ:ELDN) Rating Reiterated by HC Wainwright
Eledon Pharmaceuticals (NASDAQ:ELDN Get Free Report)s stock had its buy rating reissued by analysts at HC Wainwright in a note issued to investors on Friday, Benzinga...
Zolmax·1y ago

Latest ELDN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.